Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-15-Speech-1-059"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20031215.6.1-059"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"Mr President, Commissioner, this is the second reading of a very important legislative measure on specifications for the quality and safety of human tissues and cells for use in transplants, the priority objective of which is to provide a very high level of protection for human health. It is a fact that tissues and cells help on a daily basis to restore health, which is why we need to lay down a specific European framework which will guarantee supply and sufficiency and, at the same time, safeguard the physical integrity of those who receive them, of the recipients. The demand for tissues and cells in Europe is far greater than the supply; thus the imports necessarily being made from third countries must respect the same legislative framework, because this is the only way to prevent the illegal trade. As regards the codes of conduct with which we are so preoccupied, everyone agrees that the new technologies must respect human dignity and the non-commercialisation of the human body. At the same time, human tissue and cell donations must be based on the free will of the donor, not the fee. The human body, as has been emphasised on numerous occasions, is inviolable and inalienable and must not therefore be turned into a source of financial gain. The compromise reached during negotiations satisfactorily covers the above principles. The addendum, whereby donors may receive compensation which is severely restricted to compensating the expenses and procedure connected with the donation, does not violate the principle of voluntary donation and allows the Member States to lay down the preconditions under which compensation may be granted. It is also a good thing that under this directive, as with blood, the data needed to ensure traceability at all stages are kept for at least thirty years after clinical use. Full and in-depth information for the donor, from a trained person, on the purpose, nature, consequences and risks involved in the donation is a necessary precondition to free consent. Protection of the donor's details and medical secrecy are, I think, satisfactorily protected by the corresponding points in the annex. I should like to mention that, even if the package of compromise amendments does not include other important points approved by the relevant committee of the European Union, I shall ultimately agree, considering that the priority is to get the present directive applied as quickly as possible. Of course we are waiting directly for the Commission proposal on the preconditions for organ transplants, as you yourself promised us Commissioner. Allow me to conclude by thanking and congratulating the rapporteur, Mr Peter Liese, on his work and on the huge effort which he made for the procedure to be concluded as quickly as possible."@en1

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph